6 Compared with placebo, semaglutide has been shown to result in greater improvements in cardiometabolic risk factors such as waist circumference, blood pressure, lipid levels, and A1C levels
Conversely, being significantly underweight can also negatively affect sperm quality
Wegovy and menstrual cycle changes According to Katrina Mattingly, MD, obesity medicine specialist and chief medical officer of physician-supervised weight loss center Options Medical Weight Loss, women have been reporting various menstrual cycle changes on Wegovyfrom lighter, shorter periods to heavier periods
Multiple injections will be required to achieve optimal results
In the wake of the success of GLP-1s, drug companies are scrambling to develop, test, and bring to market more behavior-supporting drugs
Archived from the original on July 20, 2006